Antipsychotic therapeutic drug monitoring: psychiatrists' attitudes and factors predicting likely future use.

Law, Suzanne; Haddad, Peter M; Chaudhry, Imran B; Husain, Nusrat; Drake, Richard J; Flanagan, Robert J; David, Anthony S; Patel, Maxine X

Law, Suzanne; Haddad, Peter M; Chaudhry, Imran B; Husain, Nusrat; Drake, Richard J; Flanagan, Robert J; David, Anthony S; Patel, Maxine X.

Afiliación

Law S; Institute of Psychiatry, Psychology and Neuroscience, London, UK.
Haddad PM; Greater Manchester West NHS Foundation Trust, Manchester, UK.
Chaudhry IB; University of Manchester, Manchester, UK.
Husain N; University of Manchester, Manchester, UK.
Drake RJ; Manchester Mental Health and Social Care Trust, Manchester, UK.
Flanagan RJ; Institute of Psychiatry, Psychology and Neuroscience, London, UK.
David AS; Institute of Psychiatry, Psychology and Neuroscience, London, UK.
Patel MX; Institute of Psychiatry, King's College London, Box 68, 16 DeCrespigny Park, London SE5 8AF, UK.

Ther Adv Psychopharmacol ; 5(4): 214-23, 2015 Aug.

Article en En | MEDLINE | ID: mdl-26301077

Palabras clave

antipsychotics; attitude; dose; plasma concentration; schizophrenia; therapeutic drug monitoring

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Ther Adv Psychopharmacol Año: 2015 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google